Search Results - "Cull, C. A."

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes : a prospective observational study (UKPDS 75) by STRATTON, I. M, CULL, C. A, ADLER, A. I, MATTHEWS, D. R, NEIL, H. A. W, HOLMAN, R. R

“…The relative importance of glucose and blood pressure control in type 2 diabetes remains uncertain. We assessed interactive effects of glycaemia and systolic…”
Get full text

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) by HOLMAN, R. R, CULL, C. A, TURNER, R. C

“…A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) R R Holman , C…”
Get full text

Pharmacokinetics of oral meloxicam in ruminant and preruminant calves by MOSHER, R. A, COETZEE, J. F, CULL, C. A, GEHRING, R, KuKANICH, B

“…Mosher, R. A., Coetzee, J. F., Cull, C. A., Gehring, R., KuKanich, B. Pharmacokinetics of oral meloxicam in ruminant and preruminant calves. J. vet. Pharmacol…”
Get full text

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study by Stratton, Irene M, Adler, Amanda I, Neil, H Andrew W, Matthews, David R, Manley, Susan E, Cull, Carole A, Hadden, David, Turner, Robert C, Holman, Rury R

“…Abstract Objective: To determine the relation between exposure to glycaemia over time and the risk of macrovascular or microvascular complications in patients…”
Get full text

Fecal shedding of non-O157 serogroups of Shiga toxin-producing Escherichia coli in feedlot cattle vaccinated with an Escherichia coli O157:H7 SRP vaccine or fed a Lactobacillus-based direct-fed microbial by Cernicchiaro, N, Renter, D G, Cull, C A, Paddock, Z D, Shi, X, Nagaraja, T G

“…The objectives of this study were to determine whether fecal shedding of non-O157 Shiga toxin-producing Escherichia coli (STEC) in feedlot cattle was affected…”
Get more information

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study by Adler, Amanda I, Stratton, Irene M, Neil, H Andrew W, Yudkin, John S, Matthews, David R, Cull, Carole A, Wright, Alex D, Turner, Robert C, Holman, Rury R

“…Abstract Objective: To determine the relation between systolic blood pressure over time and the risk of macrovascular or microvascular complications in…”
Get full text

Islet autoantibodies in clinically diagnosed type 2 diabetes : Prevalence and relationship with metabolic control (UKPDS 70) by DAVIS, T. M. E, WRIGHT, A. D, MEHTA, Z. M, CULL, C. A, STRATTON, I. M, BOTTAZZO, G. F, BOSI, E, MACKAY, I. R, HOLMAN, R. R

“…We examined the prevalence of islet autoantibodies and their relationship to glycaemic control over 10 years in patients diagnosed clinically with new-onset…”
Get full text

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) by BOTTAZZO, G. F, BOSI, E, CULL, C. A, BONIFACIO, E, LOCATELLI, M, ZIMMET, P, MACKAY, I. R, HOLMAN, R. R

“…Established autoimmune markers of type 1 diabetes, including islet cell autoantibodies (ICA) and autoantibodies to glutamic acid decarboxylase (GADA) have been…”
Get full text

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77 by Desai, M, Cull, C. A, Horton, V. A, Christie, M. R, Bonifacio, E, Lampasona, V, Bingley, P. J, Levy, J. C, Mackay, I. R, Zimmet, P, Holman, R. R, Clark, A

“…Aims/hypothesis Latent autoimmune diabetes in adults (LADA) is a slowly progressive form of autoimmune diabetes, with autoantibodies to islet proteins…”
Get full text

Changing aspirin use in patients with Type 2 diabetes in the UKPDS by Cull, C. A., Neil, H. A. W., Holman, R. R.

“…Aims  To examine the proportion of UK Prospective Diabetes Study (UKPDS) patients with Type 2 diabetes taking aspirin regularly for the primary and secondary…”
Get full text

Reporting of diabetes on death certificates using data from the UK Prospective Diabetes Study by Thomason, M. J., Biddulph, J. P., Cull, C. A., Holman, R. R.

“…Aims  To study the effect of age at death, sex, ethnic group, date of death, underlying cause of death and social class on the frequency of reporting diabetes…”
Get full text

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects by HASHIM, Y, SHEPHERD, D, WILTSHIRE, S, HOLMAN, R. R, LEVY, J. C, CLARK, A, CULL, C. A

“…To determine the association of three genes associated with Alzheimer's disease--butyrylcholinesterase (BcHE) on chromosome 3 q, alpha2 macroglobulin (alpha2M)…”
Get full text

Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes : UKPDS 76 by CALLE, R, MCCARTHY, M. I, MANCUSO, J, MILOS, P, FRYBURG, D, HOLMAN, R. R, BANERJEE, P, ZEGGINI, E, CULL, C. A, THORNE, K. I, WILTSHIRE, S, TERRA, S, MEYER, D, RICHMOND, J

“…Identification of variants predicting development of renal dysfunction would offer substantial clinical benefits. There is evidence that coding non-synonymous…”
Get full text

Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49) by Turner, Robert C, Cull, Carole A, Frighi, Valeria, Holman, Rury R, for the UK Prospective Diabetes Study (UKPDS) Group

“…CONTEXT Treatment with diet alone, insulin, sulfonylurea, or metformin is known to improve glycemia in patients with type 2 diabetes mellitus, but which…”
Get full text

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes by Davis, T. M. E., Mehta, Z., Mackay, I. R., Cull, C. A., Bruce, D. G., Fida, S., Rowley, M. J., Holman, R. R.

“…Aims The autoantigen SOX‐13 of the SRY‐related high mobility group box is a low‐frequency reactant in sera from patients with Type 1 diabetes. We further…”
Get full text

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) by Bottazzo, G. F., Bosi, E., Cull, C. A., Bonifacio, E., Locatelli, M., Zimmet, P., Mackay, I. R., Holman, R. R.

Get full text

Poor pregnancy outcome for women with Type 2 diabetes by Hadden, D. R., Cull, C. A., Croft, D. J., Holman, R. R.

Get full text

Performance and carcass characteristics of commercial feedlot cattle from a study of vaccine and direct-fed microbial effects on Escherichia col O157:H7 fecal shedding by Cull, C A, Renter, D G, Bello, N M, Ives, S E, Babcock, A H

“…The objective of this study was to quantify cattle performance and carcass characteristics associated with administration of a siderophore receptor and porin…”
Get full text

Approach to maintaining comparability of biochemical data during long-term clinical trials by Cull, Carole A, Manley, Susan E, Stratton, Irene M, Neil, H. Andrew W, Ross, Iain S, Holman, Rury R, Turner, Robert C, Matthews, David R

“…Our objective was to design a structured approach to maintaining comparability of biochemical data during a long clinical trial. Maintaining the comparability…”
Get full text

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) by Turner, Robert C, Holman, Rury R, Cull, Carole A, Stratton, Irene M

“…Improved blood-glucose control decreases the progression of diabetic microvascular disease, but the effect on macrovascular complications is unknown. There is…”
Get full text